Aditxt Advances ADI-100 Therapy to Human Trials

TipRanksDec 12, 2024 16:50 ET

Express News | Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic Adi Platform, Advancing Toward First-in-Human Clinical Trials

ReutersDec 12, 2024 08:15 ET

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement With Aditxt, Inc.

GlobeNewswireNov 19, 2024 07:17 ET

Aditxt | 10-Q: Q3 2024 Earnings Report

SECNov 18, 2024 17:06 ET · Announcements

Evofem Biosciences 3Q Loss/Shr 2c >EVFM

Dow JonesNov 14, 2024 16:42 ET

Express News | Evofem Biosciences Announces Financial Results for the Third Quarter of 2024

ReutersNov 14, 2024 16:36 ET